Casma Therapeutics Announces $50 Million Series B Financing

·

·

Casma Therapeutics Announces $50 Million Series B Financing

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep 10, 2020–. Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, today announced the completion of a $50 million Series B financing.
See Original Article

Lloyd's of London posts H1 loss due to Covid-19 insurance claims

Lloyd’s of London recorded a pretax loss of £400m in the first half, battered by the coronavirus pandemic, the commercial insurance market said today. Insurers around the world have paid out on event cancellation, travel, trade credit and business interruption …
See Original Article

China's Baidu is in talks to raise up to $2 billion to launch a stand-alone biotech company

Chinese search giant Baidu is in discussions with investors to raise up to $2 billion over three years for a new biotech company, a person close to the matter told CNBC. The company would be a standalone entity rather than a subsidiary of Baidu, the source …
See Original Article

European markets head for choppy open ahead of ECB meeting

London’s FTSE is expected to open 16 points lower at 5,997, Germany’s DAX up 16 points at 13,253, France’s CAC 40 up 4 points at 5,947 and Italy’s FTSE MIB 20 points lower at 19,751, according to IG. The ECB’s latest interest rate and monetary policy …
See Original Article

“Caring” solicitor undone by bad accounting system

Accounts: Solicitor let down by software. A “passionate, caring and in many respects competent” solicitor, whose firm got into a financial mess in part
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.